期刊文献+

农杆菌介导的粘帚菌遗传转化 被引量:4

Genetic transformation of the fungus Gliocladium sp.mediated by Agrobacterium tumefaciens
原文传递
导出
摘要 【目的】建立分离自西藏林芝的能够产生一系列具有抗肿瘤活性的二酮哌嗪类化合物(epipolythiodioxopiperazine,ETP)的一株冬虫夏草定殖真菌——粘帚菌(Gliocladium sp.)6.102的遗传转化体系。【方法】利用农杆菌介导的方式建立了粘帚菌的遗传转化体系;用正交试验研究了影响转化效率的因素,包括共培养所用农杆菌与真菌孢子的比例、共培养的时间、pH值和乙酰丁香酮的浓度。【结果】成功建立了农杆菌介导的粘帚菌的遗传转化体系,得到了转化的最佳条件,其转化效率为50-100个转化子/106真菌孢子。通过农杆菌介导的方式分别将潮霉素B磷酸转移酶基因(hph)和绿色荧光蛋白基因(egfp)转入粘帚菌中,实现了表达并且可以稳定存在。【结论】首次建立了农杆菌介导的粘帚菌遗传转化体系,为研究ETP化合物的生物合成及其调控机制奠定了基础。 [ Objective] To construct a transformation system in Gliocladium sp. 6. 102, a Cordyceps-colonizing fungus producing a variety of epipolythiodioxopiperazine (ETP) compounds with drug potentials. [ Methods ] Agrobacterium tumefaciens-mediated transformation (ATMT) was used to transform Gliocladit^m sp. 6. 102. The factors of bacterial cell concentration, co-cultivation time, pH and acetosyringone concentration were optimized. [ Results] A total of 50 -100 transformants per 106 fungal conidia was obtained via the optimal ATMT method. The genes encoding hygromycin B phosphotase and enhanced green fluorescent protein (EGFP) were transferred into Gliocladium sp. by the optimal ATMT method. The marker genes were successfully expressed and stably maintained in the transgenic fungus. [ Conclusion] A transformation system was established for Gliocladium sp. 6. 102 and this system may be useful to identify ETP biosynthetic genes in Gliocladium.
出处 《微生物学报》 CAS CSCD 北大核心 2013年第11期1233-1239,共7页 Acta Microbiologica Sinica
基金 中国科学院知识创新工程项目(KSCX2-EW-J-6)~~
关键词 粘帚菌 农杆菌介导的遗传转化 绿色荧光蛋白 Gliocladium sp. , Agrobacterium tumefaciens-mediated transformation, green fluorescent protein
  • 相关文献

二级参考文献148

  • 1魏鑫丽,印象初,郭英兰,沈南英,魏江春.冬虫夏草及其相关类群的分子系统学分析[J].菌物学报,2006,25(2):192-202. 被引量:79
  • 2Hawksworth DL.The fungal dimension of biodiversity:magnitude,significance,and conservation[J].Mycol Res,1991,95(6):641-655.
  • 3Schulz B,Boyle C,Draeger S,et al.Endophytic fungi:a source of novel biologically active secondary metabolites[J].Mycol Res,2002,106(9):996-1004.
  • 4Masurekar PS.Therapeutic metabolites[M] //Finkelstein DB & Ball C,Eds.Biotechnology of filamentous fungi:technology and products.Boston:Butterworth-Heinemann,1992:241-301.
  • 5Oiwa I.Antibacterial agents[M] //Omura S,Ed.The search for bioactive compounds from microorganism.New York:SpringerVerlag,1992:1-29.
  • 6Koehn FE,Carter GT.The evolving role of natural products in drug discovery[J].Nat Rev Drug Discov,2005,4 (3):206-220.
  • 7Dreyfuss MH,Chapela IH.Potential of fungi in the discovery of novel low-molecular weight pharmaceuticals[M] //Gullo VP,Ed.The discovery of natural products with therapeutic potential.Boston:Butterwoah-Heinmann,1994:49-80.
  • 8Bills GF,Platas G,Peldez F,et al.Reclassifieafion ofa pneumoeandin-produeing anamorph,Glarea lozoyensis,gen.et sp.nov.,previously identified as Zalerion arboricola[J].Mycol Res,1999,103(2):179-192.
  • 9Caporale LH.Chemical ecology:a view from the pharmaceafieal industry[J].Prac NatlAcad Sci USA,1995,92 (1):75-82.
  • 10Berdy J.Bioactive microbial metabolites[J].J Antibiot,2005,58(1):1-26.

共引文献32

同被引文献143

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部